[Clinical test of a drug: nitroimidazine (1-N-beta-ethylmorpholin-5-nitroimidazole) in genital trichomoniasis].
1970
J E Zúñiga, and
J Escobar Soto
UI
MeSH Term
Description
Entries
D007093
Imidazoles
Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009025
Morpholines
Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D002986
Clinical Trials as Topic
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Clinical Trial as Topic
D005260
Female
Females
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000981
Antiprotozoal Agents
Substances that are destructive to protozoans.
Schizonticides,Agents, Antiprotozoal
D014247
Trichomonas Vaginitis
Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.
January 2007,
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,